Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T21:22:13.499Z Has data issue: false hasContentIssue false

Predicting the benefit of screening for disease

Published online by Cambridge University Press:  14 July 2016

Neil Dubin*
Affiliation:
New York University Medical Center
*
∗Postal address: Institute of Environmental Medicine, Biostatistics and Epidemiology Laboratory, New York University Medical Center, 341 East 25th St., New York, NY10010, U.S.A.

Abstract

To evaluate the benefits and risks associated with screening for disease, a model is developed to characterize the changes in incidence and survival distributions effected by a screening program. Screening is presumed to increase survival by resulting in diagnosis of disease at earlier stages. All disease states in the model are observable, thus facilitating application to empirical data. An example of such an application using data from a breast cancer detection project is given for the case of one screening for two-stage disease having Weibull-distributed diagnosis times.

Information

Type
Research Papers
Copyright
Copyright © Applied Probability Trust 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable